Shilpa Medicare has informed that a meeting of Board of Directors of the Company will be held on February 12, 2016, to consider the un-audited financial results for the period and quarter ended December 31, 2015. Further, as per code of conduct for prevention of Insider Trading Regulations, framed and adopted in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 the Trading Window would remain closed from February 06, 2016 to February 14, 2016, for the Directors, Designated Employees, and Auditors (including dependents).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: